| Followers | 240 |
| Posts | 15523 |
| Boards Moderated | 1 |
| Alias Born | 03/29/2014 |
Monday, September 25, 2017 3:35:52 PM
I dont think the last 8K sec filing is vague at all.
I agree. I think it's clear too. They aren't speaking until that abstract is published.
The SEC requires clearly when a company should and only can use regular press releases and when a company can not. The sec also is very clear when an 8K sec filing should be issued and when not.
Well I think the SEC is very clear about what should be made public, whether it's by PR or 8-k. I disagree about them being clear about what does not need to be made public. However, if you take a look at the section 8.01 marked "Other", you'll find that there are many, many things a company does not need to make public.
https://www.sec.gov/about/forms/form8-k.pdf
The registrant ****MAY****, at its option, disclose under this Item 8.01 any events, with respect to which information is not otherwise called for by this form, that the registrant deems of importance to security holders. The registrant may, at its option, file a report under this Item 8.01 disclosing the nonpublic information required to be disclosed by Regulation FD (17 CFR 243.100 through 243.103)
Take a look at this link - Section 8.01 - page 21.
https://www.sec.gov/files/form8-k.pdf
It becomes much clearer upon reading.
Now we have seen an 8K sec filing on the 22nd. Apparently now NWBO is anticipating something material which before June 5 was not the case. So in the last 8K they cannot, legally mathematically not talk about just blinded data of which they anticipate the disclosure of. AKA yet another "Dr Bosch presentation". It can only, therefore, mean that they are waiting for the disclosure (which according to Oxford dictionary means Allow (something hidden) to be seen!)
Yes... we have seen an 8k filed. I believe the one and only reason the 8-k was filed was to let long shareholders know they would not be speaking at SMi, and the reason why. However as you note in your quote above, while they could "legally" speak about whatever they want, it would not be in the company's best interest, which includes the shareholders as a whole, to speak about the data they anticipate presenting.
or in other words unblinding the blinded data
Well, to be "crystal clear", the 8-kwords don't state that. They state "interim blinded data". Nothing there about awaiting unblinded data. That doesn't mean they/we aren't awaiting unblinded data, but that is not the reason stated for LP not attending SMi.
Because they have also stated its about interim data, it must be the anticipating of the unblinding of PFS data...
And that's where I'd have to disagree with you... it is most clearly not about unblinding anything that LP is not attending SMi. Please remember, this 8-K was intended only disclose why the company is not attending SMi. Nothing else. And it clearly relates to awaiting "blinded interim data". Not unblinded.
And to restate, that doesn't mean they/we aren't awaiting unblinded data as well. But that's not what caused them to not attend SMi.
That's my opinion anyway. :)
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
